StonvexLoading…
StonvexStonvexStonvexCore line items from PSHG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $84.17M | $87.44M | $108.94M | $75.17M |
Operating Income | $51.94M | $41.81M | $75.53M | $39.98M |
Net Income | $49.97M | $43.73M | $69.41M | $36.30M |
EPS (Diluted) | $1.28 | $1.11 | $1.91 | $3.02 |
Total Assets | $559.85M | $330.39M | $296.27M | $292.98M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $48.17M | $70.31M | $67.27M | $38.73M |
Free Cash Flow OCF − CapEx | $50.08M | $59.66M | $67.44M | $31.74M |
Shares Outstanding | 12.43M | 12.43M | 12.28M | 4.19M |